메뉴 건너뛰기




Volumn 115, Issue 2, 2015, Pages 176-177

How active should active surveillance be?

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

EID: 84921464214     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12859     Document Type: Editorial
Times cited : (1)

References (6)
  • 1
    • 84921526102 scopus 로고    scopus 로고
    • Indications for intervention during active surveillance of prostate cancer: A comparison of the Johns Hopkins and Prostate Cancer Research International Active Surveillance (PRIAS) protocols
    • Kates M, Tosoian JJ, Trock BJ, Feng Z, Carter HB, Partin AW,. Indications for intervention during active surveillance of prostate cancer: a comparison of the Johns Hopkins and Prostate Cancer Research International Active Surveillance (PRIAS) protocols. BJU Int 2015; 115: 216-222
    • (2015) BJU Int , vol.115 , pp. 216-222
    • Kates, M.1    Tosoian, J.J.2    Trock, B.J.3    Feng, Z.4    Carter, H.B.5    Partin, A.W.6
  • 2
    • 79953767326 scopus 로고    scopus 로고
    • The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer
    • Whitson JM, Porten SP, Hilton JF, et al. The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer. J Urol 2011; 185: 1656-1660
    • (2011) J Urol , vol.185 , pp. 1656-1660
    • Whitson, J.M.1    Porten, S.P.2    Hilton, J.F.3
  • 3
    • 34247630061 scopus 로고    scopus 로고
    • Prostate-specific antigen levels as a predictor of lethal prostate cancer
    • Fall K, Garmo H, Andrén O, et al. Prostate-specific antigen levels as a predictor of lethal prostate cancer. J Natl Cancer Inst 2007; 99: 526-532
    • (2007) J Natl Cancer Inst , vol.99 , pp. 526-532
    • Fall, K.1    Garmo, H.2    Andrén, O.3
  • 4
    • 79957957477 scopus 로고    scopus 로고
    • Active surveillance program for prostate cancer: An update of the Johns Hopkins experience
    • Tosoian JJ, Trock BJ, Landis P, et al. Active surveillance program for prostate cancer: an update of the Johns Hopkins experience. J Clin Oncol 2011; 29: 2185-2190
    • (2011) J Clin Oncol , vol.29 , pp. 2185-2190
    • Tosoian, J.J.1    Trock, B.J.2    Landis, P.3
  • 5
    • 73949130115 scopus 로고    scopus 로고
    • Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
    • Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A,. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010; 28: 126-131
    • (2010) J Clin Oncol , vol.28 , pp. 126-131
    • Klotz, L.1    Zhang, L.2    Lam, A.3    Nam, R.4    Mamedov, A.5    Loblaw, A.6
  • 6
    • 77953120925 scopus 로고    scopus 로고
    • Prostate cancer death of men treated with initial active surveillance: Clinical and biochemical characteristics
    • Krakowsky Y, Loblaw A, Klotz L,. Prostate cancer death of men treated with initial active surveillance: clinical and biochemical characteristics. J Urol 2010; 184: 131-135
    • (2010) J Urol , vol.184 , pp. 131-135
    • Krakowsky, Y.1    Loblaw, A.2    Klotz, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.